A middle-aged woman sustained serious heart valve injury (i.e.
primary pulmonary hypertension) from taking a prescribed diet drug
Redux, which contains Fen/Phen. Our firm maintained joint responsibility with an experienced drug injury
firm who settled the case.
$2.5 Million Settlement
A wife and mother of two children died of a cerebral hemorrhage
after taking an over the counter diet drug diet drug containing
Ephedra. The deceased’s husband contacted our firm for help.
Our firm maintained joint responsibility with an experienced product liability attorney who settled
the case.
$900,000 Settlement
We were co-counsel in a case involving a dietary supplement with
PPA. The client suffered a stroke and had a brain bleed that required
two surgeries. Our firm maintained joint responsibility with an experienced product liability attorney
who settled the case.
$ 750,000 Settlement
A teenager committed suicide after taking an anti-depressant drug
for several weeks. The young boy’s life was cut short just
one week before his birthday. Our firm maintained joint responsibility with an experienced product liability
attorney who settled the case.
$1.25 Million Settlement
Our client was the mother of a one year old child who was born with a complex cardiovascular condition. The child was diagnosed with arterial septal defect, ventricular septal defect and congestive heart failure, all conditions caused by the mother's use of Paxil during the first trimester of her pregnancy. Our firm maintained joint responsibility with an experienced drug injury firm who settled the case.
$800,000 Settlement
When Baycol was removed from the market in 2001, we were contacted by many Rhode Islanders who were injured by this medication. Our firm maintained joint responsibility with an experienced attorney in pharmaceutical litigation, who was successful in negotiating a multi-million dollar settlement for several clients.
$2 Million in total Settlements
Due to taking the drug zyprexa, a number of our clients developed type 2 diabetes as a side effect. Our firm maintained joint responsibility with a pharmaceutical litigation law firm, who was successful in negotiating a multi-million dollar settlement for our clients.
$3.8 Million in total
Settlements
A Connecticut man was diagnosed with Type II diabetes after using the medication, Zyprexa. Our firm maintained joint responsibility with an experienced attorney in pharmaceutical litigation, and the case was settled out of court.
$500,000 Settlement

Are you a woman who took Depakote during pregnancy or a young adult who has suffered from birth defects? Recent evidence has arisen which indicates that mothers who took Depakote during their first trimester of pregnancy have experienced frequent incidences of birth defects in their children. More common birth defects associated with the use of Depakote include spina bifida, cleft palate limb malformation, and genital malformation. If you or your child has suffered as a result of birth defects from the use of Depakote, you need an experienced law firm who handles pharmaceutical injury cases. Contact the Law Offices of d’Oliveira & Associates today to get in touch with a personal injury lawyer who can help you pursue your Depakote lawsuit.
Depakote is a prescription medication used to treat epilepsy and manic episodes associated with bipolar disorder. Manufactured by Abbott Laboratories, Depakote (divalproex sodium and/or valproic acid) was released onto the market in 1983 for the treatment of epilepsy. In 1995, Depakote was approved for the treatment of manic episodes in patients suffering from bipolar disorder. Following this success, physicians began prescribing the drug to treat migraine headaches and other neuropathy conditions. However, since giving its approval, the FDA has issued numerous warnings pertaining to the dangerous side effects and risks associated with Depakote.
In 2006, the FDA issued a black box warning (the strongest possible warning the agency can give) for Depakote. This warning cautioned women of childbearing age that the benefits of Depakote use might be outweighed by the serious risks the medication poses to unborn fetuses. Additionally, the black box warning indicated that potential Depakote side effects may also include liver failure or pancreatitis in some individuals.
The major side effects of using Depakote include:
The most serious of these side effects is the increased risk for birth defects in children whose mothers were using Depakote during pregnancy. Many studies have shown that antiepileptic (or anticonvulsant) medications, such as Depakote, can lead to major birth defects. A study performed at five Boston area hospitals over a 7-year period found that over 20 percent of newborns whose mothers used antiepileptic drugs, such as Depakote, during pregnancy had serious birth defects.
Furthermore, in the August 8, 2006 issue of Neurology, a study reported that major birth defects and even fetal deaths were much more likely to occur in pregnant women using Depakote than any other antiepileptic medication. This study also collected data suggesting that the toddlers of women who used Depakote during pregnancy scored nearly 8 points lower in I.Q. testing than other toddlers whose mothers used other antiepileptic drugs. As compared to other antiepileptic medication options, the study also found that the chances of the child being mentally retarded were double if the mother was using Depakote. This information led the Neurodevelopmental Effects of Antiepileptic Drugs study group to conclude that Depakote should be at the “bottom of the list” of recommended antiepileptic drugs.
As compared to other antiepileptic medication options, the study also found that the chances of the child being mentally retarded were double if the mother was using Depakote. This information led the Neurodevelopmental Effects of Antiepileptic study group to conclude that Depakote should be at the “bottom of the list” of recommended antiepileptic drugs.
All of the data and information gathered on the dangers of Depakote recently led the FDA to take additional action. In December 2009, the FDA issued a statement warning physicians and patients about the very serious birth defects associated with the use of Depakote during pregnancy. In an effort to assist patients in weighing these risks, the FDA now requires that a medication guide be provided with the antiepileptic drug. This guide warns patients of the many side effects, including birth defects, that may occur with the use of Depakote.
The types of birth defects linked to Depakote include:
Spina bifida is the most common type of neural tube defect. It occurs when the embryonic neural tube is not completely formed. This neural tube malformation results in the child having an opening in the vertebrae, leaving their spinal cord exposed. This birth defect typically occurs just weeks after conception. Although most warnings have cautioned women not to take Depakote while they are pregnant, some data also suggests that women should be weary of taking Depakote after pregnancy. The drug may pass through the breast milk, causing the baby to suffer the dangerous side effects of Depakote.
The long list of birth defects is frightening. Many of these side effects are considered life threatening. Additionally, many of the possible birth defects that may occur as a result of using Depakote cannot be corrected through surgical procedures or treatments. This means that the child could potentially suffer from a non-fatal birth defect for the rest of their lives.
PLEASE SPEAK WITH YOUR DOCTOR BEFORE DISCONTINUING THE USE OF DEPAKOTE OR ANY OTHER PRESCRIPTION DRUGS.
If you believe that you or a loved one has suffered as a result of taking Depakote, you may want to speak with an injury attorney, today, regarding your potential lawsuit. A personal injury lawyer familiar with new developments in the investigation of Depakote may be able to help you make important personal and legal decisions.
Please contact the law offices of d'Oliveira & Associates at 1-800-992-6878 or fill out a contact form for a free legal consultation.